Clinical development of Modified Vaccinia virus Ankara vaccines.

Clinical development of Modified Vaccinia virus Ankara vaccines.

Бусад хувилбаруудыг харуулах (1)

The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Gilbert, S
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2013

Ижил төстэй зүйлс

Clinical development of Modified Vaccinia virus Ankara vaccines
-н: Gilbert, S
Хэвлэсэн: (2013)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
-н: Olga Vladimirovna Orlova, зэрэг
Хэвлэсэн: (2022-09-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
-н: Gilbert, S, зэрэг
Хэвлэсэн: (1999)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
-н: Moorthy, V, зэрэг
Хэвлэсэн: (2003)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
-н: Kaïdre Bendjama, зэрэг
Хэвлэсэн: (2017-09-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
-н: Volker Sandig, зэрэг
Хэвлэсэн: (2013-11-01)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
-н: Juan García-Arriaza, зэрэг
Хэвлэсэн: (2021-08-01)

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans
-н: Alina Tscherne, зэрэг
Хэвлэсэн: (2024-11-01)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
-н: López-Camacho, C, зэрэг
Хэвлэсэн: (2019)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
-н: Alharbi, N
Хэвлэсэн: (2014)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
-н: César López-Camacho, зэрэг
Хэвлэсэн: (2019-11-01)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
-н: Caroline Staib, зэрэг
Хэвлэсэн: (2003-04-01)

Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine
-н: Harriet L. Robinson, зэрэг
Хэвлэсэн: (2018-09-01)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
-н: McConkey, S, зэрэг
Хэвлэсэн: (2003)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
-н: Rosario, M, зэрэг
Хэвлэсэн: (2010)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
-н: Flavia Chiuppesi, зэрэг
Хэвлэсэн: (2024-02-01)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
-н: Mingwang Shen, зэрэг
Хэвлэсэн: (2024-10-01)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
-н: Alharbi, N, зэрэг
Хэвлэсэн: (2015)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
-н: C. Staib, зэрэг
Хэвлэсэн: (2000-06-01)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
-н: Malachy I. Okeke, зэрэг
Хэвлэсэн: (2017-10-01)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.
-н: Naif Khalaf Alharbi, зэрэг
Хэвлэсэн: (2015-01-01)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
-н: Moorthy, V, зэрэг
Хэвлэсэн: (2003)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
-н: Moorthy, V, зэрэг
Хэвлэсэн: (2003)

Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)
-н: Schmidt, C, зэрэг
Хэвлэсэн: (2008)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
-н: Behboudi, S, зэрэг
Хэвлэсэн: (2004)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
-н: Schneider, J, зэрэг
Хэвлэсэн: (1998)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
-н: Dorrell, L, зэрэг
Хэвлэсэн: (2000)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
-н: Nereida Jiménez de Oya, зэрэг
Хэвлэсэн: (2022-03-01)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
-н: Hanke, T, зэрэг
Хэвлэсэн: (1998)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
-н: Cottingham, M, зэрэг
Хэвлэсэн: (2008)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified <i>Vaccinia virus</i> Ankara (MVA)
-н: Maurilia Marcacci, зэрэг
Хэвлэсэн: (2020-07-01)

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant
-н: Ning Yang, зэрэг
Хэвлэсэн: (2022-10-01)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
-н: Winslow, R, зэрэг
Хэвлэсэн: (2017)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
-н: Matthew G Cottingham, зэрэг
Хэвлэсэн: (2008-02-01)

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
-н: David A Garber, зэрэг
Хэвлэсэн: (2009-01-01)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
-н: Goepfert P, зэрэг
Хэвлэсэн: (2012-09-01)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
-н: McConkey, S, зэрэг
Хэвлэсэн: (2003)

Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model.
-н: Miriam Nörder, зэрэг
Хэвлэсэн: (2010-01-01)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
-н: Mcshane, H, зэрэг
Хэвлэсэн: (2001)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
-н: Hanke, T, зэрэг
Хэвлэсэн: (2007)